Moleculin Biotech, Inc.
Moleculin Biotech, Inc.（MBRX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · MBRX · 截至 2026年6月9日
活动摘要
买入笔数
4
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Moleculin Biotech, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
MBRX 季度内部人买卖趋势
MBRX 内幕交易卖出 · MBRX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · MBRX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
MBRX 高管卖出股份 · MBRX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Nov 4, 2025 | PICKER DONALD H Chief Science Officer | Option | 8,750 | — | Form 4 |
| Nov 4, 2025 | PICKER DONALD H Chief Science Officer | Other | 2,131 | $1K | Form 4 |
| Nov 4, 2025 | KLEMP WALTER V CEO and President · Director | Option | 28,750 | — | Form 4 |
| Nov 4, 2025 | KLEMP WALTER V CEO and President · Director | Other | 7,001 | $3K | Form 4 |
| Nov 4, 2025 | Foster Jonathan P. CFO | Option | 20,625 | — | Form 4 |
| Nov 4, 2025 | Foster Jonathan P. CFO | Option | 5,023 | $2K | Form 4 |
| Jun 23, 2025 | Foster Jonathan P. CFO | Purchase | 270,270 | $100K | Form 4 |
| Jun 22, 2025 | Foster Jonathan P. CFO | Option | 4,328 | — | Form 4 |
| Jun 22, 2025 | Foster Jonathan P. CFO | Other | 1,054 | $281 | Form 4 |
| Jun 20, 2025 | Foster Jonathan P. CFO | Option | 2,711 | — | Form 4 |
| Jun 20, 2025 | Foster Jonathan P. CFO | Other | 661 | $176 | Form 4 |
| Jun 23, 2025 | KLEMP WALTER V CEO and President · Director | Purchase | 675,675 | $250K | Form 4 |
| Jun 22, 2025 | KLEMP WALTER V CEO and President · Director | Option | 8,990 | — | Form 4 |
| Jun 22, 2025 | KLEMP WALTER V CEO and President · Director | Other | 2,190 | $585 | Form 4 |
| Jun 20, 2025 | KLEMP WALTER V CEO and President · Director | Option | 3,750 | — | Form 4 |
| Jun 20, 2025 | KLEMP WALTER V CEO and President · Director | Other | 914 | $244 | Form 4 |
| Jun 22, 2025 | PICKER DONALD H Chief Science Officer | Option | 1,766 | — | Form 4 |
| Jun 22, 2025 | PICKER DONALD H Chief Science Officer | Other | 430 | $115 | Form 4 |
| Jun 20, 2025 | PICKER DONALD H Chief Science Officer | Option | 1,078 | — | Form 4 |
| Jun 20, 2025 | PICKER DONALD H Chief Science Officer | Other | 263 | $70 | Form 4 |
| Jun 16, 2025 | Foster Jonathan P. CFO | Option | 833 | — | Form 4 |
| Jun 16, 2025 | Foster Jonathan P. CFO | Other | 203 | $139 | Form 4 |
| Jun 16, 2025 | KLEMP WALTER V CEO and President · Director | Option | 1,667 | — | Form 4 |
| Jun 16, 2025 | KLEMP WALTER V CEO and President · Director | Other | 406 | $278 | Form 4 |
| Jul 2, 2024 | KLEMP WALTER V CEO and President · Director | Option | 982 | — | Form 4 |
KLEMP WALTER V
CEO and President · Director
日期
Jun 23
股数
675,675
均价
$0.37
总金额
$250K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 MBRX 内幕交易
MBRX 内幕交易
Moleculin Biotech, Inc.（MBRX）内幕交易数据来源于公司内部人（包括KLEMP WALTER V (CEO and President · Director), Foster Jonathan P. (CFO), PICKER DONALD H (Chief Science Officer)）提交的SEC Form 4申报文件。过去12个月内，3位内部人向SEC提交了交易申报。MBRX内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Moleculin Biotech, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
MBRX 内幕交易 · 5个问题Moleculin Biotech, Inc.（MBRX）的内部人包括高管和董事，如KLEMP WALTER V (CEO and President · Director), Foster Jonathan P. (CFO), PICKER DONALD H (Chief Science Officer)等。过去12个月内，3位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026